Literature DB >> 33386655

Primary prevention of COVID-19: advocacy for vaccination from a neurological perspective.

Johann Sellner1,2,3, Tom Jenkins4,5, Tim von Oertzen6,7, Claudio L Bassetti8, Ettore Beghi9, Daniel Bereczki10, Benedetta Bodini11, Francesco Cavallieri12, Giovanni Di Liberto13, Raimund Helbok14, Antonella Macerollo15,16, Luis F Maia17,18, Celia Oreja-Guevara19, Serefnur Özturk20, Martin Rakusa21, Anna Sauerbier22,23, Riccardo Soffietti24, Pille Taba25, Antonio Pisani26, Alberto Priori27, Marialuisa Zedde12, Michael Crean28, Anja Burlica28, Alex Twardzik28, Elena Moro29.   

Abstract

Immunization by means of vaccination is a global health success story, saving millions of lives every year. In this regard, the epidemiology of measles, rabies, polio, rubella, varicella, influenza and mumps infections, all of which can harm the nervous system, could be contained by global vaccination campaigns. In addition, toxoid vaccines against bacterial toxins such as tetanus and diphtheria are indispensable and effective interventions for toxin-mediated neurologic diseases. This article is protected by copyright. All rights reserved.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; advocacy; global health; neurology; primary prevention; vaccination

Year:  2021        PMID： 33386655     DOI： 10.1111/ene.14713

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN： 1351-5101            Impact factor:   6.089


  8 in total

1.  A plea for equitable global access to COVID-19 diagnostics, vaccination and therapy: The NeuroCOVID-19 Task Force of the European Academy of Neurology.

Authors:  Johann Sellner; Thomas M Jenkins; Tim J von Oertzen; Claudio L Bassetti; Ettore Beghi; Daniel Bereczki; Benedetta Bodini; Francesco Cavallieri; Giovanni Di Liberto; Raimund Helbok; Antonella Macerollo; Luis F Maia; Celia Oreja-Guevara; Serefnur Özturk; Martin Rakusa; Antonio Pisani; Alberto Priori; Anna Sauerbier; Riccardo Soffietti; Pille Taba; Marialuisa Zedde; Michael Crean; Anja Burlica; Alex Twardzik; Elena Moro
Journal:  Eur J Neurol       Date:  2021-02-05       Impact factor: 6.288

Review 2.  Multiple Sclerosis and SARS-CoV-2 Vaccination: Considerations for Immune-Depleting Therapies.

Authors:  Johann Sellner; Paulus S Rommer
Journal:  Vaccines (Basel)       Date:  2021-01-28

3.  Humoral Immune Response after the Third SARS-CoV-2 mRNA Vaccination in CD20 Depleted People with Multiple Sclerosis.

Authors:  Lutz Achtnichts; Barbara Jakopp; Michael Oberle; Krassen Nedeltchev; Christoph Andreas Fux; Johann Sellner; Oliver Findling
Journal:  Vaccines (Basel)       Date:  2021-12-11

Review 4.  Coronavirus disease 2019 (Covid-19) vaccination recommendations in special populations and patients with existing comorbidities.

Authors:  Zeinab Mohseni Afshar; Arefeh Babazadeh; Alireza Janbakhsh; Feizollah Mansouri; Terence T Sio; Mark J M Sullman; Kristin Carson-Chahhoud; Rezvan Hosseinzadeh; Mohammad Barary; Soheil Ebrahimpour
Journal:  Rev Med Virol       Date:  2021-10-22       Impact factor: 11.043

5.  SARS-CoV-2 mRNA Vaccination in People with Multiple Sclerosis Treated with Fingolimod: Protective Humoral Immune Responses May Develop after the Preferred Third Shot.

Authors:  Lutz Achtnichts; Arkady Ovchinnikov; Barbara Jakopp; Michael Oberle; Krassen Nedeltchev; Christoph Andreas Fux; Johann Sellner; Oliver Findling
Journal:  Vaccines (Basel)       Date:  2022-02-21

6.  Lessons learned from people with neurological diseases at the time of COVID-19: The EFNA-EAN survey.

Authors:  Benedetta Bodini; Elena Moro; Joke Jaarsma; Elizabeth Cunningham; Johann Sellner; Donna Walsh
Journal:  Eur J Neurol       Date:  2021-10-05       Impact factor: 6.089

7.  COVID-19 vaccination hesitancy among people with chronic neurological disorders: A position paper.

Authors:  Martin Rakusa; Serefnur Öztürk; Elena Moro; Raimund Helbok; Claudio L Bassetti; Ettore Beghi; Daniel Bereczki; Benedetta Bodini; Giovanni Di Liberto; Thomas M Jenkins; Antonella Macerollo; Luis F Maia; Filippo Martinelli-Boneschi; Antonio Pisani; Alberto Priori; Anna Sauerbier; Riccardo Soffietti; Pille Taba; Tim J von Oertzen; Marialuisa Zedde; Michael Crean; Anja Burlica; Francesco Cavallieri; Johann Sellner
Journal:  Eur J Neurol       Date:  2022-05-10       Impact factor: 6.288

8.  Myopathy as a cause of fatigue in long-term post-COVID-19 symptoms: Evidence of skeletal muscle histopathology.

Authors:  Eva K Hejbøl; Thomas Harbo; Jane Agergaard; Line B Madsen; Thomas H Pedersen; Lars J Østergaard; Henning Andersen; Henrik D Schrøder; Hatice Tankisi
Journal:  Eur J Neurol       Date:  2022-06-23       Impact factor: 6.288
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.